Baes, Luzminda S.

HRN: 26-95-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/12/2025
04/19/2025
IV
500MG
Q6
Septic Shock Prob Sec To Intraabdominal Infection
Waiting Final Action 
04/12/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/12/2025
04/19/2025
IV
4.5g
Q8
Septic Shock Prob Sec To Intraabdominal Infection
Waiting Final Action 
04/16/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/16/2025
04/22/2025
IV
600 Mg
Q6
Abscess
Waiting Final Action 
04/16/2025
AZITHROMYCIN 500MG TABLET (TAB)
04/16/2025
04/22/2025
PO
500 Mg
Od
Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: